NON-INVASIVE CANCER SOLUTIONS
Safe | Accurate | Easy on the Patient
WORLDWIDE
Outstanding Benefits for Patients
Outstanding Benefits for Patients
Breast Cancer
- 39 years old
- Female patient
- Cancer had persisted after 5 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentBreast Cancer
- 53 years old
- Female patient
- Cancer had persisted after 10 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentOvarian Cancer
- 48 years old
- Female patient
- Cancer had persisted after 3 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentNeuroendocrine Tumor of Cervix
- 41 years old
- Female patient
- Cancer had persisted after 4 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentGallbladder Cancer
- 32 years old
- Female patient
- Cancer had persisted after 2 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentLeiomyosarcoma
- 53 years old
- Female patient
- Cancer had persisted after 2 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentMelanoma
- 46 years old
- Female patient
- Cancer had persisted after 5 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentLung Cancer
- 62 years old
- Male patient
- Cancer had persisted after 4 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentHead and Neck Cancer
- 42 years old
- Male patient
- Cancer had persisted after 5 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentHead and Neck Cancer
- 51 years old
- Male patient
- Cancer had persisted after 3 lines of therapy
Before
Resilient Protocol with Exacta Analysis
After TreatmentHead and Neck Cancer
- 65 years old
- Female patient
- Cancer had persisted after 3 lines of therapy
Day 0
Day 30
Day 79CONTACT US
Please contact us for more details.